Tg(CAG-Bgeo,-SMN2)E9Dscd
Transgene Detail
|
Symbol: |
Tg(CAG-Bgeo,-SMN2)E9Dscd |
Name: |
transgene insertion E9, Dawn S Chandler |
MGI ID: |
MGI:5427354 |
Synonyms: |
Tg hSMN2 E9 |
Transgene: |
Tg(CAG-Bgeo,-SMN2)E9Dscd Location: unknown
|
Alliance: |
Tg(CAG-Bgeo,-SMN2)E9Dscd page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:185111
|
Parent Cell Line: |
TC1/TC-1 (ES Cell)
|
Strain of Origin: |
129S6/SvEvTac
|
|
Transgene Type: |
|
Transgenic (Conditional ready, Humanized sequence, Inserted expressed sequence, Reporter) |
Mutation: |
|
Insertion
|
|
|
Mutation details: The pCCALL2/hSMN2 transgene was designed with, from 5' to 3', the CMV-IE enhancer/chicken beta-actin/rabbit beta-globin hybrid promoter (originally from the pCAGG vector), a loxP-flanked STOP cassette (beta-galactosidase/neomycin resistance cassette [beta-geo] with three copies of the SV40 polyA signal), the 1.37 kbp full-length human SMN2 cDNA sequence including all exons (1-8) from the start codon to the stop codon, and a rabbit polyA signal. The 1.37 kbp human SMN2 cDNA sequence (encoding exons 1-8) was originally derived via RT-PCR performed on total RNA isolated from SMA type 1-derived patient fibroblast cells (Coriell Institute GM 3813; shown to express both full-length and truncated SMN2 transcripts). Lines A9 and E9 was generated.
(J:185111)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:185111 Bebee TW, et al., Generation of a tamoxifen inducible SMN mouse for temporal SMN replacement. Genesis. 2011 Dec;49(12):927-34 |
All: |
1 reference(s) |
|